Innate lymphoid cells in graft-versus-host disease

American Journal of Transplantation

Volumn 15, Issue 11, 2015, Pages 2795-2801

  Konya, V ^a,b   Mjosberg J ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CD103 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 25; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7 RECEPTOR ALPHA; INTERLEUKIN 9; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

BLOOD ANALYSIS; CD8+ T LYMPHOCYTE; CLINICAL CLASSIFICATION; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CYTOTOXICITY; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HELPER CELL; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE RESPONSE; INDUCTION CHEMOTHERAPY; INNATE IMMUNITY; INTESTINE GRAFT; INTESTINE INFECTION; LAMINA PROPRIA; LYMPHOID CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII; ADVERSE EFFECTS; ALLOTRANSPLANTATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY; LYMPHOCYTE; MALE; ORGAN TRANSPLANTATION; PHYSIOLOGY; PROCEDURES; PROGNOSIS;

FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; LYMPHOCYTES; MALE; ORGAN TRANSPLANTATION; PROGNOSIS; T-LYMPHOCYTES, HELPER-INDUCER; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84944570278     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13394     Document Type: Review

References (38)

1. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, et al., Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008; 29: 958-970.
2. Monticelli LA, Sonnenberg GF, Abt MC, et al., Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 2011; 12: 1045-1054.
3. Sonnenberg GF, Fouser LA, Artis D,. Border patrol: Regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 2011; 12: 383-390.
4. Hazenberg MD, Spits H,. Human innate lymphoid cells. Blood 2014; 124: 700-709.
5. Spits H, Artis D, Colonna M, et al., Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13: 145-149.
6. Diefenbach A, Colonna M, Koyasu S, Development, differentiation, and diversity of innate lymphoid cells. Immunity 2014; 41: 354-365.
7. Constantinides MG, McDonald BD, Verhoef PA, Bendelac A,. A committed precursor to innate lymphoid cells. Nature 2014; 508: 397-401.
8. Montaldo E, Teixeira-Alves LG, Glatzer T, et al., Human RORgammat(+)CD34(+) cells are lineage-specified progenitors of group 3 RORgammat(+) innate lymphoid cells. Immunity 2014; 41: 988-1000.
9. Hanash AM, Dudakov JA, Hua G, et al., Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 2012; 37: 339-350.
10. Munneke JM, Bjorklund AT, Mjosberg JM, et al., Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood 2014; 124: 812-821.
11. Fuchs A, Vermi W, Lee JS, et al., Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells. Immunity 2013; 38: 769-781.
12. Bernink JH, Peters CP, Munneke M, et al., Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013; 14: 221-229.
13. Klose CS, Flach M, Mohle L, et al., Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 2014; 157: 340-356.
14. Moro K, Yamada T, Tanabe M, et al., Innate production of T(H) 2 cytokines by adipose tissue-associated c-Kit(+) Sca-1(+) lymphoid cells. Nature 2010; 463: 540-544.
15. Neill DR, Wong SH, Bellosi A, et al., Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010; 464: 1367-1370.
16. Price AE, Liang HE, Sullivan BM, et al., Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 2010; 107: 11489-11494.
17. Mjosberg J, Bernink J, Golebski K, et al., The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 2012; 37: 649-659.
18. Mjosberg JM, Trifari S, Crellin NK, et al., Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12: 1055-1062.
19. Kim BS, Siracusa MC, Saenz SA, et al., TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med 2013; 5: 170ra16.
20. Teunissen MB, Munneke JM, Bernink JH, et al., Composition of innate lymphoid cell subsets in the human skin: Enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol 2014; 134: 2351-2360.
21. Mjosberg J, Eidsmo L,. Update on innate lymphoid cells in atopic and non-atopic inflammation in the airways and skin. Clin Exp Allergy 2014; 44: 1033-1043.
22. Hams E, Armstrong ME, Barlow JL, et al., IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc Natl Acad Sci USA 2014; 111: 367-372.
23. Eberl G, Marmon S, Sunshine MJ, Rennert PD, Choi Y, Littman DR,. An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 2004; 5: 64-73.
24. Cupedo T, Crellin NK, Papazian N, et al., Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 2009; 10: 66-74.
25. Spits H, Cupedo T,. Innate lymphoid cells: Emerging insights in development, lineage relationships, and function. Annu Rev Immunol 2012; 30: 647-675.
26. Glatzer T, Killig M, Meisig J, et al., RORgammat(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 2013; 38: 1223-1235.
27. Sonnenberg GF,. Regulation of intestinal health and disease by innate lymphoid cells. Int Immunol 2014; 26: 501-507.
28. Sonnenberg GF, Monticelli LA, Alenghat T, et al., Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012; 336: 1321-1325.
29. Sanos SL, Vonarbourg C, Mortha A, Diefenbach A,. Control of epithelial cell function by interleukin-22-producing RORgammat+ innate lymphoid cells. Immunology 2011; 132: 453-465.
30. Keefe DM, Brealey J, Goland GJ, Cummins AG,. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000; 47: 632-637.
31. Blazar BR, Murphy WJ, Abedi M,. Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 2012; 12: 443-458.
32. Hill GR, Ferrara JL,. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: Rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754-2759.
33. Asplund S, Gramlich TL,. Chronic mucosal changes of the colon in graft-versus-host disease. Mod Pathol 1998; 11: 513-515.
34. Sato T, Vries RG, Snippert HJ, et al., Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009; 459: 262-265.
35. Ahlfors H, Morrison PJ, Duarte JH, et al., IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection. J Immunol 2014; 193: 4602-4613.
36. Dudakov JA, Hanash AM, Jenq RR, et al., Interleukin-22 drives endogenous thymic regeneration in mice. Science 2012; 336: 91-95.
37. Sabat R, Ouyang W, Wolk K,. Therapeutic opportunities of the IL-22-IL-22R1 system. Nat Rev Drug Discov 2014; 13: 21-38.
38. Ferrara JL, Harris AC, Greenson JK, et al., Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood 2011; 118: 6702-6708.